Large pelvic mass invading into the sacrum: a case report for primary retroperitoneal P16 positive squamous cell carcinoma

Background: This case report reviews a rare form of Human Papilloma Virus (HPV)-associated squamous cell carcinoma—primary retroperitoneal disease. Case: A 69-years old female presented to Kingston General Hospital with signs and symptoms concerning for cauda equina and underwent spinal magnetic resonance imaging which demonstrated a multicystic and solid mass invading into her sacrum in addition to significant pelvic lymphadenopathy. An imaging-guided biopsy demonstrated HPV-positive squamous cell carcinoma, of unknown origin. Given the presence of symptomatic disease on initial presentation, she underwent palliative radiation. Once she was discharged in stable condition from hospital, the Gynecologic Oncology team assumed care due to the location of the mass, despite not clearly originating from the cervix. She completed 4 cycles of systemic chemotherapy with carboplatin and paclitaxel. She also received bevacizumab and immunotherapy with pembrolizumab. Over a number of subsequent visits and repeat imaging, there was a drastic reduction of tumour burden in response to this treatment regimen and no evidence of disease progression after 15 months of follow up. Conclusions: This is a novel case for retroperitoneal squamous cell carcinoma treated with systemic chemotherapy as well as immunotherapy resulting in a significant treatment response.

Squamous cell carcinoma; Human papilloma virus; Retroperitoneum

[1] Collado Martín R, García Palomo A, de la Cruz Merino L, Borrega García P, Barón Duarte FJ; Spanish Society for Medical Oncology. Clinical guideline SEOM: cancer of unknown primary site. Clinical & Translational Oncology. 2014; 16: 1091–1097.

[2] Matsuzaka Y, Yamaguchi K, Moriyoshi K, Takao Y, Takakura K, Konishi I. Primary retroperitoneal squamous cell carcinoma: a case report with review of the literature. International Cancer Conference Journal. 2019; 8: 61–65.

[3] Khalil AM, Shabb NS, Hourani MH, Shamseddine AI, El-Hajj MI, Seoud AF. Primary squamous cell carcinoma of the pelvic retroperitoneum presenting as an adnexal mass: a case report. Journal of Obstetrics and Gynaecology. 2005; 25: 92–93.

[4] Matsuyama S, Nakafusa Y, Tanaka M, Yoda Y, Mori D, Miyazaki K. Iliac lymph node metastasis of an unknown primary tumor: report of a case. Surgery Today. 2006; 36: 655–658.

[5] Clements A, Euscher E, Lacour R, Merritt W, Klopp A, Ramondetta L. The presence of human papillomavirus or p16 in six cases of retroperitoneal carcinoma. Obstetrics & Gynecology. 2010; 116: 1042–1046.

[6] Ryu MJ, Chung YW, Bae HS, Lee JK, Lee NW, Song JY. Primary squamous cell carcinoma arising from the pelvic retroperitoneum. Korean Journal of Obstetrics & Gynecology. 2012; 55: 782–786.

[7] Oh HJ, Park EH, Lee YB, Hu J, Lee GJ, Chun SH, et al. HPV-related retroperitoneal squamous cell carcinoma of unknown primary: a case report. Cancer Research and Treatment. 2015; 47: 954–957.

[8] Ahdallah R, Morse B, Hakam A, Shahzad MM. Pelvic squamous cell carcinoma of unknown primary: a case report and review of the literature. European Journal of Gynaecological Oncology. 2016; 37: 430–433.

[9] Isbell A, Fields EC. Three cases of women with HPV-related squamous cell carcinoma of unknown primary in the pelvis and retroperitoneum: a case series. Gynecologic Oncology Reports. 2016; 16: 5–8.

[10] Agrawal A, Chibbar R, Safavi-Naini A. HPV related retroperitoneal squamous cell cancer: a rare presentation. Journal of Cancer Therapy. 2016; 07: 901–907.

[11] Cucinella G, Sozzi G, Di Donna MC, Unti E, Mariani A, Chiantera V. Retroperitoneal squamous cell carcinoma involving the pelvic side wall arising from endometriosis: a case report. Gynecologic and Obstetric Investigation. 2022; 87: 159–164.

[12] Zhu QZ, Li HJ, Li YQ, Yu XH, Shu KY. Pelvic metastatic squamous cell carcinoma of unknown primary site: a case report and brief literature review. Medicine. 2023; 102: e36796.

[13] Matylevich OP, Kurchankou MA, Kopsсhaj PA, Schmeler KM. HPV-related metastatic retroperitoneal pelvic squamous cell carcinoma of unknown primary origin in a patient previously treated for endometrial cancer. International Journal of Surgery Case Reports. 2024; 118: 109624.

[14] Koge H, Hino A, Kakiuchi A, Yamamoto Y, Kanbe A, Kojima D, et al. A case of pelvic squamous cell carcinoma of unknown primary origin that responded well to radiotherapy and nivolumab. Radiology Case Reports. 2024; 19: 1881–1885.

[15] Schatz JE, Colgan TJ. Squamous metaplasia of the peritoneum. Archives of Pathology & Laboratory Medicine. 1991; 115: 397–398.

[16] Chen CH, Yeh SD, Chiou JF, Lin YH, Chang CW. Optimum treatment for primary squamous cell carcinoma of the pelvic retroperitoneum. Journal of Experimental & Clinical Medicine. 2011; 3: 304–306.

[17] Pandey A, Kumar D, Gupta P, Khosla D, Periasamy K, Kapoor R. Primary retroperitoneal squamous cell carcinoma: a literature review. Journal of Cancer Research and Clinical Oncology. 2023; 149: 12507–12512.

[18] Colombo N, Dubot C, Lorusso D, Caceres MV, Hasegawa K, Shapira-Frommer R, et al.; KEYNOTE-826 investigators. Pembrolizumab for persistent, recurrent, or metastatic cervical cancer. The New England Journal of Medicine. 2021; 385: 1856–1867.

[19] Suzuki R, Hamada K, Ohkuma R, Homma M, Tsurui T, Iriguchi N, et al. Case report: combined pembrolizumab, 5-fluorouracil, and cisplatin therapy were remarkably effective in p16-positive squamous cell carcinoma of unknown primary. Frontiers in Oncology. 2023; 13: 1231986.